Further considerations in the therapy with ara-C.
D000818:Animals; D003561:Cytarabine / Q000627:therapeutic use*; D004351:Drug Resistance; D004357:Drug Synergism; D005472:Fluorouracil / Q000627:therapeutic use; D051379:Mice; D008937:Mitomycins / Q000627:therapeutic use; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D013866:Thioguanine / Q000627:therapeutic use
D008937:Mitomycins; D003561:Cytarabine; D013866:Thioguanine; D005472:Fluorouracil